Table 3.
Use of various Cur-loaded LNPs against different types of cancers.
| Cancer Type | LNPs | Particle Size (nm) | Preparation Methods | References |
|---|---|---|---|---|
| Lung cancer | SLN | 20–80 | Sol-gel | [144] |
| Liver cancer | NLC | 90 | High-pressure microfluidics | [145] |
| Colon cancer | SLN | <500 | Coacervation | [146] |
| Breast cancer | SLN | 152 | High pressure homogenization | [147] |
| Breast cancer | SLN | 194 | High pressure homogenization | [148] |
| Endometrial cancer | Liposomes | 100–150 | Thin-film hydration | [149] |
| Cervical cancer | Liposome | 350–390 | Thin-film hydration | [150] |
| Hepatocellular cancer | Chitosan coated liposome | 240 | Thin-film hydration | [151] |
| Breast cancer | Surface modified liposomes | 207–297 | Thin-film hydration | [152] |
| Breast cancer | NE | 199 | Nanoemulsification | [153] |
| Lung and liver cancer | SLN | 104.1 | Thin-film ultrasonic hydration method | [154] |
| Breast cancer | SLN | 175–190 | Cold dilution of microemulsion | [155] |
| Liver cancer | NE | 114.7 | Emulsification method | [156] |
| Breast cancer | NE | 40 | Emulsification method | [157] |
| Stomach cancer | NLC | 11–50 | High pressure homogenization | [158] |
| Lung cancer | liposome | 80–100 | Thin-film hydration | [159] |
| Liver cancer | liposome | 90–120 | Thin-film hydration | [160] |